Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.
Impact in
- Immunology 382
- Oncology 229
Classified as
- Journal
- PubMed
In The Last Decade
doi.org/w73835262 →Countries where authors are citing Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.
This map shows the geographic impact of Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host. more than expected).
Fields of papers citing Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.
This network shows the impact of Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host..
About Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.
This paper, published in 1960, received 563 indexed citations . Written by George Klein, Hans Olof Sjögren, Eva Klein and Karl Erik Hellström covering the research area of Immunology. It is primarily cited by scholars working on Immunology (382 citations), Oncology (229 citations), Molecular Biology (165 citations), Genetics (79 citations) and Radiology, Nuclear Medicine and Imaging (74 citations). Published in PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/w73835262.